Loading quotes...
Forecast
The analysts' average price target is €13.39 (+41.39%). The median is €13.39 (+41.39%).
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 237.41m | 7.37% |
| Gross profit | 142.2m | 8.38% |
| Net profit | -355.8m | 2,943.27% |
| EBITDA | -290.5m | 447.80% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.62bn |
Number of shares | 169.9m |
52-week high/low | €11.85 - €4.12 |
| Dividends | No |
Beta | 1.81 |
P/E ratio | -26.47 |
PEG ratio | -0.40 |
P/B ratio | 1.87 |
P/S ratio | 1.64 |
Company profile
| Name | Trulieve Cannabis |
| CEO | Kimberly A. Rivers |
| Employees | 5,000 |
